These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11874188)

  • 1. Growth hormone therapy may increase fracture risk in a pubertal patient with osteogenesis imperfecta.
    Noda H; Onishi H; Saitoh K; Nakajima H
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):217-8. PubMed ID: 11874188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of synthetic salmon calcitonin therapy in children with osteogenesis imperfecta.
    Rebelo I; da Silva LP; Blanco JC; Monteiro ME; Ferreira NC
    J Int Med Res; 1989; 17(4):401-5. PubMed ID: 2792559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta: Are fractures and growth hormone treatment linked?
    Kodama H; Kubota K; Abe T
    J Pediatr; 1998 Mar; 132(3 Pt 1):559-60. PubMed ID: 9544925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C
    Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramedullary osteosynthesis for fracture associated with osteogenesis imperfecta.
    Wolf H; Sarahrudi K; Vécsei V
    Injury; 2009 Mar; 40(3):315-20. PubMed ID: 19243773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous nailing in the management of osteogenesis imperfecta.
    Sijbrandij S
    Int Orthop; 1990; 14(2):195-7. PubMed ID: 2373568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.
    Hald JD; Evangelou E; Langdahl BL; Ralston SH
    J Bone Miner Res; 2015 May; 30(5):929-33. PubMed ID: 25407702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.
    Zacharin M; Kanumakala S
    J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1511-7. PubMed ID: 15570988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for Improving Bone Mineral Density and Reducing Fracture Risk in Osteogenesis Imperfecta: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    Curr Clin Pharmacol; 2018; 13(3):190-198. PubMed ID: 30160216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta.
    Nishi Y; Hamamoto K; Kajiyama M; Ono H; Kihara M; Jinno K
    J Pediatr; 1992 Sep; 121(3):477-80. PubMed ID: 1517930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children with Osteogenesis imperfecta in Estonia.
    Maasalu K; Haviko T; Märtson A
    Acta Paediatr; 2003 Apr; 92(4):452-5. PubMed ID: 12801112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta after the menopause.
    Paterson CR; McAllion S; Stellman JL
    N Engl J Med; 1984 Jun; 310(26):1694-6. PubMed ID: 6727948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
    Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):17-26. PubMed ID: 11220700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood.
    Feehan AG; Zacharin MR; Lim AS; Simm PJ
    Bone; 2018 Aug; 113():137-143. PubMed ID: 29787832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.
    Gatti D; Antoniazzi F; Prizzi R; Braga V; Rossini M; Tatò L; Viapiana O; Adami S
    J Bone Miner Res; 2005 May; 20(5):758-63. PubMed ID: 15824848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare combination of amniotic constriction band with osteogenesis imperfecta.
    Shah KH; Shah H
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26561227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture of mandible during yawning in a patient with osteogenesis imperfecta.
    Ram H; Shadab M; Vardaan A; Aga P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25103485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta.
    Bhadada SK; Santosh R; Bhansali A; Upreti V; Dutta P
    J Assoc Physicians India; 2009 Jan; 57():33-6. PubMed ID: 19753756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.